SARcode Bioscience, Inc.

Sector:
Healthcare

Location:
Brisbane, CA

Year Funded:
2011

Status:
Acquired by Shire Pharmaceuticals

Website:
www.sarcode.com




Summary:
SARcode Bioscience, Inc., founded in 2006, is a venture-backed ophthalmic biopharmaceutical company. SARcode’s lead development program is a novel class of lymphocyte function-associated antigen-1 (LFA-1) antagonists for the treatment T-cell mediated inflammatory diseases.